Recombinant Clostridium botulinum translation initiation factor IF-2 (infB), partial, refers to a genetically engineered fragment of the bacterial protein IF-2 encoded by the infB gene. IF-2 is essential for initiating protein synthesis by promoting ribosomal subunit association, recruiting the initiator tRNA (fMet-tRNA), and facilitating its binding to the ribosomal P-site . The "partial" designation indicates that the recombinant form lacks full-length sequence integrity, likely retaining functional domains such as GTPase activity or ribosomal binding regions.
The infB gene in bacteria typically encodes two isoforms (IF2α and IF2β) via alternative translational initiation sites. Key structural features include:
In Clostridium botulinum, the infB gene structure and domain organization are inferred from homologs like Bacillus and E. coli.
Recombinant IF-2 fragments are generated using expression systems such as E. coli or C. botulinum vectors. Key steps include:
Cloning: Amplification of the infB fragment (e.g., G2-G3 or C1-C2 domains) into plasmids (e.g., pMVP410) .
Expression: Induction in bacterial hosts under controlled conditions.
Purification: Affinity chromatography (e.g., Ni-NTA for His-tagged proteins) .
Functional Assays:
Studying ribosomal initiation mechanisms in pathogenic clostridia.
Developing inhibitors targeting IF-2’s GTPase domain for antimicrobial purposes.
No direct structural or functional data on C. botulinum IF-2 exists in the reviewed literature.
Most insights are extrapolated from Bacillus or E. coli homologs .
Structural Resolution: Cryo-EM or X-ray crystallography of C. botulinum IF-2.
Functional Knockout Studies: Assess IF-2’s role in toxin production or sporulation.
Therapeutic Exploration: Screen IF-2 inhibitors against botulism.
KEGG: cbh:CLC_2265
Translation Initiation Factor 2 (IF-2) in C. botulinum, like in other bacteria, consists of five structural domains with distinct functions :
N-domain (N-terminal domain): Less conserved, rich in alanine and charged amino acids, weakly structured, and dispensable for basic translational functions.
GI domain (residues 228-412 in B. stearothermophilus): Highly conserved and contains all structural motifs characteristic of GTP/GDP-binding proteins.
GII domain (residues 413-520): A highly conserved β-barrel module structurally homologous to domain II of elongation factors.
C-1 domain: A sturdy domain rich in helical structures.
C-2 domain (last 110 amino acids): Responsible for recognition and binding of fMet-tRNA.
Functionally, IF-2 catalyzes the binding of initiator fMet-tRNA in the ribosomal P site, increasing both the rate and fidelity of translation initiation . This positioning is essential for correct start codon selection and assembly of the complete translation initiation complex.
The interaction between IF-2 and the ribosome involves specific contacts with both ribosomal subunits :
The GII domain of IF-2 is in proximity to helices H3, H4, H17, and H18 of 16S rRNA in the small subunit.
The junction of the C-1 and C-2 domains is near H89 and the thiostrepton region of 23S rRNA in the large subunit.
The C-2 domain is positioned close to P-site-bound tRNA.
The conserved GI domain interacts with the large subunit's factor-binding center.
Research suggests that the orientation of IF-2 on the 30S subunit changes during the transition from the 30S to 70S initiation complex . This dynamic positioning is crucial for proper formation of the translation initiation complex and subsequent protein synthesis.
Recombinant C. botulinum IF-2 provides researchers with several advantages:
It allows for controlled expression and purification of the protein for in vitro translation studies.
Enables structure-function relationship studies through site-directed mutagenesis.
Facilitates comparative studies between C. botulinum and other bacterial IF-2 proteins.
Helps understand potential differences in translation initiation machinery that might be unique to this pathogenic organism.
Could provide insights for developing targeted interventions against botulism.
Understanding the translation mechanisms of C. botulinum contributes to our knowledge of how this pathogen functions at the molecular level, potentially revealing new approaches to combat botulism .
Expressing recombinant C. botulinum proteins presents several significant challenges:
Expression system selection: Research on recombinant botulinum neurotoxins has shown that proteins produced in heterologous systems (e.g., E. coli) may have different properties compared to those expressed in endogenous systems. For example, endogenously produced mutant botulinum neurotoxins had ~100-1000-fold greater toxicity than their heterologously produced counterparts .
Protein folding and solubility issues: Large multi-domain proteins like IF-2 often face folding challenges in heterologous systems.
Codon optimization requirements: C. botulinum has different codon usage patterns compared to common expression hosts.
Potential toxicity to host cells: Some C. botulinum proteins may interfere with host cell processes.
Post-translational modifications: Differences between expression hosts and C. botulinum may affect protein function.
The choice between heterologous and endogenous expression systems should be carefully considered based on specific research questions .
The effects of mutations in different IF-2 domains vary based on the domain's role:
Experimental approaches to study these effects include site-directed mutagenesis, chemical modification of specific amino acids (e.g., using tethered nucleases), truncation analysis, and complementation studies with domain swaps from other species.
CRISPR-Cas9 technology offers powerful approaches for studying IF-2 function in C. botulinum, similar to methods described for studying other genes in this organism :
Gene modification strategies:
Complementation studies:
Protocol implementation:
Design sgRNAs targeting the infB gene regions of interest
Create repair templates containing homology arms, desired mutations, and bookmark sequences
Deliver CRISPR-Cas9 components and repair template into C. botulinum
Screen transformants for successful editing
For complementation, design new sgRNAs targeting the bookmark sequence
Deliver CRISPR-Cas9 components with a repair template containing the wild-type sequence
This approach provides precise genetic manipulation while maintaining genomic context, allowing for rigorous functional studies of IF-2 in its native environment .
Several complementary techniques provide valuable insights into IF-2-ribosome interactions:
Chemical nuclease probing:
Cryo-electron microscopy (cryo-EM):
Visualization of IF-2 in ribosomal complexes at near-atomic resolution
Capturing different states of the initiation complex
Fluorescence-based approaches:
Förster resonance energy transfer (FRET) between labeled IF-2 and ribosomal components
Single-molecule FRET to observe dynamic changes during initiation
Cross-linking methods:
Site-specific cross-linking using bifunctional reagents
UV cross-linking with photoreactive amino acid analogs
Biochemical assays:
| Technique | Advantages | Limitations | Resolution |
|---|---|---|---|
| Chemical nuclease probing | Precise interaction mapping; works in solution | Requires engineering cysteines; potential structural perturbation | 5-10 Å |
| Cryo-EM | Direct visualization; no labels needed | Requires stable complexes; averaging of states | 2.5-4 Å |
| FRET | Dynamic measurements; works in solution | Requires fluorescent labeling; indirect measurement | 10-100 Å |
| Cross-linking | Captures transient interactions | Can create artifacts; challenging analysis | Residue-specific |
| Biochemical assays | Functional relevance; quantitative | Indirect; limited structural information | N/A |
Integrating these complementary approaches provides the most comprehensive understanding of IF-2-ribosome interactions .
Purification of recombinant C. botulinum IF-2 requires careful consideration of protein properties:
Recommended purification protocol:
Expression system selection:
Affinity tag selection:
Cell lysis conditions:
Buffer: 50 mM Tris-HCl pH 7.5, 300 mM NaCl, 5% glycerol, 1 mM DTT
Protease inhibitor cocktail to prevent degradation
Gentle lysis methods (e.g., lysozyme treatment followed by sonication)
Purification steps:
Immobilized metal affinity chromatography (IMAC) with Ni-NTA resin
Ion exchange chromatography using Resource Q column
Size exclusion chromatography for final polishing
Quality control assessments:
SDS-PAGE to verify purity
Mass spectrometry for accurate mass determination
Circular dichroism to verify secondary structure
Functional assays (GTP binding, fMet-tRNA binding)
When using different expression systems, it's critical to compare protein properties as significant functional differences have been observed between endogenously and heterologously expressed C. botulinum proteins .
When faced with contradictory results between heterologously and endogenously expressed recombinant C. botulinum proteins, researchers should follow this analytical framework:
Systematic property comparison:
Structural integrity assessment through circular dichroism or limited proteolysis
Specific activity comparison in functional assays
Post-translational modification analysis by mass spectrometry
System-specific considerations:
Expression system effects on folding pathways
Different chaperone proteins influencing final structure
Codon usage differences affecting co-translational folding
Biological relevance evaluation:
Based on research with recombinant botulinum neurotoxins, endogenously produced mutants showed ~100-1000-fold greater toxicity than their heterologously produced counterparts . This significant difference highlights the importance of expression system choice and suggests that endogenous expression may better preserve native protein properties for functional studies.
Statistical analysis of IF-2 functional data requires approaches specific to the assays employed:
For binding assays (IF-2-ribosome, IF-2-fMet-tRNA):
Nonlinear regression to determine dissociation constants (Kd)
Scatchard analysis for multiple binding sites
One-way ANOVA with post-hoc tests for comparing multiple variants
For GTPase activity measurements:
Michaelis-Menten kinetics analysis to determine Km and kcat
Lineweaver-Burk plots to identify inhibition mechanisms
Two-way ANOVA for comparing effects of mutations and conditions
For in vitro translation assays:
Paired t-tests for comparing wild-type and mutant activities
Multiple regression for analyzing effects of various factors
Power analysis to determine appropriate sample sizes
For ribosome interaction studies:
Cluster analysis of chemical probing data
Bootstrap analysis for structure prediction reliability
Bayesian methods for integrating multiple data types
Recommended reporting practices:
Include a minimum of three independent biological replicates
Report both raw data and processed results when possible
Present exact p-values rather than threshold cutoffs
Use appropriate multiple testing corrections
Include measures of dispersion (standard deviation or standard error)
These statistical approaches ensure robust interpretation of experimental data when studying the complex functions of IF-2.
Integrating structural and functional data requires a systematic approach:
Mapping functional data onto structural models:
Identify residues critical for specific functions through mutagenesis
Correlate chemical modification sites with functional effects
Visualize conserved regions in the context of the 3D structure
Developing structure-based hypotheses:
Predict effects of mutations based on structural context
Design targeted mutations to test specific structural features
Use computational docking to model protein-protein interactions
Model refinement process:
Integration methodologies:
Combine low-resolution techniques (SAXS, cryo-EM) with high-resolution data
Use distance constraints from FRET and cross-linking
Apply molecular dynamics simulations to model conformational changes
This integrated approach can yield a dynamic model of IF-2 function that explains both structural arrangements and functional data, particularly for understanding the transition between 30S and 70S initiation complexes .
Several contradictions exist in the research regarding IF-2 positioning:
30S vs. 70S complex differences: Research suggests the orientation of IF-2 on the 30S subunit changes during the transition to the 70S initiation complex , but the exact nature of these changes remains debated.
Cross-linking vs. cryo-EM data discrepancies: Different techniques have yielded somewhat different models for IF-2 positioning on the ribosome.
Species-specific variations: Differences observed between IF-2 positioning in different bacterial species raise questions about the universality of proposed models.
Dynamic vs. static models: Some research supports a more dynamic model of IF-2 function with multiple conformations during initiation, while other data suggests more stable positioning.
Resolving these contradictions requires integrating multiple experimental approaches:
Cryo-EM studies at different stages of initiation
Time-resolved FRET experiments to capture dynamic changes
Cross-validation between chemical cross-linking and structural biology methods
Comparative studies between C. botulinum IF-2 and homologs from other species
Understanding these contradictions is essential for developing accurate models of IF-2 function during translation initiation .